In mid-September, we suggested that investors take a closer look at Pfizer, the big ($211 billion market cap) pharmaceutical company. This article is for paid members - please login or subscribe for access. Username Password Remember Me Forgot Password Share: Mark W. Guthner, CFA Previous Post AMAT: Applied MaterialsNext PostThe bullish case for gold, silver and bitcoin in the long run You Might Also Like Is Tesla (TSLA) About to Play Catchup March 6, 2020 Crypto Update November 7, 2020 Is it Time to Drive a Ford? March 15, 2018
You Might Also Like Is Tesla (TSLA) About to Play Catchup March 6, 2020 Crypto Update November 7, 2020 Is it Time to Drive a Ford? March 15, 2018
